Samantha Willing
Human Resources Officer en ATHIRA PHARMA, INC. .
Origen de la red de primer grado Samantha Willing.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Extinct | Biotechnology | 15 | |
| Public Company | Biotechnology | 15 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Samantha Willing a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Public Communications Contact | |
| SEAGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| Stanford University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| Western Washington University | College/University | Undergraduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| RELYPSA INC | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Chief Operating Officer | |
| 89BIO, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Juvaris BioTherapeutics, Inc.
 Juvaris BioTherapeutics, Inc. BiotechnologyHealth Technology Juvaris BioTherapeutics, Inc. develops novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The company was founded by Martin D. Cleary, Jeff Fairman and Steven W. Dow in February 2003 and is headquartered in Burlingame, CA. | Biotechnology | Chief Executive Officer Director/Board Member | |
AOBiome Therapeutics, Inc.
 AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Turn Therapeutics(TM), Inc
 Turn Therapeutics(TM), Inc Medical SpecialtiesHealth Technology Turn Therapeutics(TM), Inc is a pharmaceutical and medical device organization that aims to reduce the human and economic costs of infection and skin disease. Turn Therapeutics(TM is based in Calabasas, CA. The private company's core mission is to innovate and educate in order to render disease obsolete. The company has multiple, mass market-ready, proprietary assets incorporating advanced delivery and healing technologies, including their FDA cleared product, Hexagen® wound dressing, which is non-irritating, non-cytotoxic, and non-sensitizing, as well as suitable for extended-wear. The company was founded by Bradley Burnam, who has been the CEO since incorporation. | Medical Specialties | Director/Board Member | |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Public Communications Contact | |
| University of British Columbia | College/University | Undergraduate Degree | |
| SYNLOGIC, INC. | Biotechnology | Chief Operating Officer | |
| University of Victoria | College/University | Masters Business Admin | |
| WAVE LIFE SCIENCES LTD. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania | College/University | Undergraduate Degree | |
| Stanford University School of Medicine | College/University | Undergraduate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Wave Life Sciences UK Ltd.
 Wave Life Sciences UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Wave Life Sciences Ltd., Wave Life Sciences UK Ltd. is a pharmaceutical company founded in 2017. The private company is based in Birmingham, UK and specializes in manufacturing pharmaceutical products. | Pharmaceuticals: Major | Director/Board Member | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree | |
| DORMAN PRODUCTS, INC. | Automotive Aftermarket | Director/Board Member | |
| CYTEIR THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| UCLA Anderson School of Management | College/University | Masters Business Admin | |
| Hastings College | College/University | Graduate Degree | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| ZS PHARMA INC | Pharmaceuticals: Major | Director/Board Member | |
| OMEGA ALPHA SPAC | Financial Conglomerates | Director/Board Member | |
| PRELUDE THERAPEUTICS INCORPORATED | Biotechnology | Director/Board Member | |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a precision medicines company called Esker that aims to provide personalized treatments for people with autoimmune diseases. The company is based in San Francisco, CA. Esker uses a precision analytics platform, powered by foresite labs, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology to create medicines that change the lives of people with autoimmune disease. The company was founded by June H Lee. Martin Babler has been the CEO of the company since 2021. | Pharmaceuticals: Major | Chief Executive Officer | |
| Sardona Therapeutics, Inc. | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 36 |
| Canadá | 7 |
| Reino Unido | 3 |
| Singapur | 2 |
| Islas Caimán | 2 |
Sectorial
| Health Technology | 30 |
| Consumer Services | 11 |
| Commercial Services | 4 |
| Consumer Durables | 2 |
| Finance | 2 |
Operativa
| Director/Board Member | 86 |
| Corporate Officer/Principal | 60 |
| Independent Dir/Board Member | 34 |
| Chairman | 29 |
| Undergraduate Degree | 29 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| John Fluke | 30 |
| Lewis Williams | 23 |
| Sean Nolan | 18 |
| Barbara Kosacz | 17 |
| Amber Caska | 17 |
| Kelly Romano | 16 |
| Joseph Edelman | 15 |
| Andrew Gengos | 15 |
| Martin Babler | 13 |
| Mark Litton | 11 |
| Rohan Palekar | 10 |
| Michael Panzara | 9 |
| James Johnson | 9 |
| Donna Cochener-Metcalfe | 9 |
| Kamran Alam | 9 |
- Bolsa de valores
- Insiders
- Samantha Willing
- Conexiones Empresas
